Intuitive Surgical (NASDAQ:ISRG) Trading 1.3% Higher – Time to Buy?

Intuitive Surgical, Inc. (NASDAQ:ISRG) traded up 1.3% during mid-day trading on Thursday . The stock traded as high as $584.08 and last traded at $580.02. 400,239 shares were traded during mid-day trading, a decline of 79% from the average session volume of 1,931,788 shares. The stock had previously closed at $572.71.

Wall Street Analyst Weigh In

A number of research firms have recently commented on ISRG. Wells Fargo & Company lifted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Truist Financial increased their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday. CICC Research started coverage on shares of Intuitive Surgical in a research note on Monday. They set a “neutral” rating and a $550.00 price target for the company. Finally, Piper Sandler restated an “overweight” rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Price Performance

The stock has a market cap of $206.65 billion, a price-to-earnings ratio of 93.28, a PEG ratio of 5.19 and a beta of 1.39. The company’s 50 day moving average is $549.32 and its 200 day moving average is $507.50.

Insider Buying and Selling

In related news, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. The trade was a 1.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 28,843 shares of company stock valued at $15,357,560. 0.90% of the stock is owned by insiders.

Hedge Funds Weigh In On Intuitive Surgical

Institutional investors and hedge funds have recently modified their holdings of the company. Everhart Financial Group Inc. raised its holdings in Intuitive Surgical by 4.9% in the 4th quarter. Everhart Financial Group Inc. now owns 3,196 shares of the medical equipment provider’s stock valued at $1,668,000 after acquiring an additional 150 shares during the last quarter. Aveo Capital Partners LLC acquired a new position in Intuitive Surgical in the fourth quarter valued at $276,000. Empire Life Investments Inc. purchased a new position in Intuitive Surgical during the fourth quarter worth about $2,529,000. Nations Financial Group Inc. IA ADV boosted its stake in Intuitive Surgical by 5.5% in the 4th quarter. Nations Financial Group Inc. IA ADV now owns 829 shares of the medical equipment provider’s stock worth $433,000 after buying an additional 43 shares during the last quarter. Finally, Spinnaker Trust purchased a new stake in Intuitive Surgical in the 4th quarter valued at about $201,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.